Focus: Medcaptain Medical Technology is a publicly-traded Chinese biotechnology company founded in 2011, specializing in infusion devices and respiratory therapeutics. The company operates from Shenzhen with a focus on established pharmaceutical products.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Medcaptain Medical Technology to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Short-acting benzodiazepine CNS depressant at peak commercial maturity; primary revenue anchor for the company.
Help build intelligence for Medcaptain Medical Technology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Medcaptain Medical Technology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Cholinergic antagonist facing near-term loss of exclusivity with no disclosed generic mitigation strategy.
Dual-mechanism antidote for organophosphorus poisoning approaching LOE; niche indication limits market scale.
No open positions listed yet.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo